Patent ID: 8530175

Claim:
A method of monitoring efficacy of a treatment of a diabetes or pre-diabetes condition in a subject, comprising: measuring binding of a plurality of lectins to a first sample from the subject; administering a treatment to the subject; measuring binding of the plurality of lectins to a second sample from the subject after administering the treatment to the subject; and comparing the binding of the plurality of lectins to the first sample to the binding of the plurality of lectins to the second sample, wherein the plurality of lectins comprises Aleuria aurantia lectin, Concanavalin A, Phaseolus vulgaris agglutinin, Datura stramonium lectin, and Sambucus nigra lectin; and wherein a decrease in the binding of each of the plurality of lectins to the second sample relative to the binding of each of the plurality of lectins to the first sample indicates that the treatment is effective, and/or wherein an increase in the binding of each of the plurality of lectins to the second sample relative to the binding of each of the plurality of lectins to the first sample indicates that the treatment is ineffective.